Search results
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition
Investing.com· 3 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Short Interest Update
ETF DAILY NEWS· 1 day agoActinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,980,000 ...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted...
Newswise· 2 days agoMD Anderson and Replay today announced that the Food & Drug Administration (FDA) has issued a ‘safe to proceed’ for the Investigational New Drug (IND) appli
Cullinan Oncology, Inc. (NASDAQ:CGEM) Sees Large Growth in Short Interest
ETF DAILY NEWS· 3 days agoCullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 1,680,000 shares ...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
Vor Biopharma’s (VOR) “Outperform” Rating Reiterated at Wedbush
ETF DAILY NEWS· 6 days agoWedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report released on Tuesday, Benzinga reports. Wedbush currently has a $11.00 price ...
How Big Pharma Is Taking A Page Out Of Novartis' Playbook
Investor's Business Daily· 7 days agoNovartis (NVS) blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that sends radiation directly to cancer cells. Novartis' prostate cancer drug, Pluvicto, which ...